Alector, Inc. Current Liabilities
Alector, Inc. (ALEC) had Current Liabilities of $34.24 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-06
- 2026-06-30: Liabilities, Current $34.24M.
- 2026-03-31: Liabilities, Current $40.97M.
- 2025-12-31: Liabilities, Current $69.50M.
- 2025-09-30: Liabilities, Current $79.96M.
| Period end | Liabilities, Current |
|---|---|
| 2026-06-30 | $34.24M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $40.97M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $69.50M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $79.96M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $84.35M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $109.77M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $125.06M 10-K · filed 2026-02-25 |
| 2024-09-30 | $142.53M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $147.68M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $164.92M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $177.95M 10-K · filed 2025-02-26 |
| 2023-09-30 | $155.40M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $132.27M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $99.30M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $93.81M 10-K · filed 2024-02-27 |
| 2022-09-30 | $160.89M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $149.41M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $142.88M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $139.56M 10-K · filed 2023-02-28 |
| 2021-09-30 | $132.81M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $74.39M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $64.06M 10-Q · filed 2021-05-05 |
| 2020-12-31 | $68.09M 10-K · filed 2022-02-24 |
| 2020-09-30 | $71.09M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $65.86M 10-Q · filed 2020-08-11 |
| 2020-03-31 | $71.78M 10-Q · filed 2020-05-13 |
| 2019-12-31 | $61.97M 10-K · filed 2021-02-25 |
| 2019-09-30 | $58.72M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $67.10M 10-Q · filed 2019-08-12 |
| 2019-03-31 | $55.83M 10-Q · filed 2019-05-13 |
| 2018-12-31 | $47.95M 10-K · filed 2020-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |